The Hershey Company (HSY) — Q2 2026 Earnings Preview

Company

The Hershey Company

Ticker

HSY

Earnings Date

July 30, 2026 (Pre-Market)

Prepared

July 29, 2026

Reporting Period

Q2 2026 (ended June 28, 2026)

Sector ETF Benchmark

XLP (Consumer Staples Select Sector SPDR)

1. Earnings Preview

Key Takeaway: The setup is cautiously constructive — consensus is a manageable bar after Q1 pull-forward distortion, but the single biggest swing factor is whether Q2 organic sales land at or above the guided "slightly negative" level and whether management upgrades full-year guidance at the midyear checkpoint.

Bar: Consensus organic sales growth for Q2 2026 sits at approximately −1.3% (Visible Alpha), reflecting management’s explicit guidance for a slightly negative quarter driven by Easter timing pull-forward into Q1 and the intentional reduction of private-label salty snacks production. This is a deliberately low bar, and any outperformance on core branded consumption — particularly North America Confectionery — could drive a beat. Adjusted EPS consensus of approximately $1.43 is similarly modest, with gross margin expected to expand nearly 300 bps year-over-year as higher-cost cocoa begins to lap.

Guidance/Tone: Management reaffirmed full-year 2026 guidance on the Q1 call (April 30) and reiterated confidence at the Goldman Sachs Consumer Staples Forum (May 12), noting that elasticities are running "more favorably than original expectations" and that all key operating areas are "performing inside the expectations" set for the year. The tone has been deliberately measured — management explicitly said it would "not change the guide" despite a strong Q1 beat, citing price pack architecture still rolling out and macro uncertainty (SNAP, gas prices). The midyear checkpoint on July 30 is the first natural opportunity to raise guidance.

Estimate Trajectory: Q2 2026 adjusted EPS estimates have drifted modestly lower since the Q1 print (from ~$1.55 in February to ~$1.43 currently), consistent with management’s own guidance for a timing-impacted quarter. Full-year 2026 EPS consensus of ~$8.43 is essentially unchanged since the Q1 print, suggesting the Street is holding its powder for a potential guidance raise. The gap between current consensus and the guidance midpoint (~$8.36) is narrow, leaving limited cushion if execution disappoints.

Stock Setup: HSY has underperformed both XLP (+3.6%) and the S&P 500 (+1.5%) since the Q1 earnings date (April 30), declining approximately −1.0% through July 29. The stock trades at ~19.8x NTM P/E, down sharply from ~31x a year ago as multiple compression has dominated the return profile. At current levels, the stock is not pricing in a beat — it is pricing in execution risk. A clean Q2 print with a guidance raise could be a meaningful catalyst.

Wildcard: The single biggest wildcard is cocoa cost trajectory and tariff relief. Mondelez (reporting July 28, one day prior) flagged a cocoa surplus of at least 500,000 metric tons — 10% of total demand — and expressed confidence in 2027 earnings insulation from commodity volatility. If Hershey echoes this view and signals that 2027 cocoa coverage is locking in at favorable levels, the stock could re-rate meaningfully. Conversely, any commentary suggesting tariff relief on cocoa is stalling or that H2 gross margin expansion is at risk would be a negative surprise.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus sets a deliberately low bar for Q2 — organic sales are guided slightly negative due to timing, while gross margin is the more important swing factor, expected to expand ~300 bps year-over-year. Adjusted EPS and organic sales growth are the two KPIs most likely to drive the stock on results day.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Estimate

YoY Change

FY 2026 Guidance

Consensus vs. Guidance

Net Sales ($M)

$3,104

$2,615

$2,636

+0.8%

4%–5% total growth

Tracking low end

Organic Sales Growth (%)

+7.9%

+26.3%

−1.3%

−27.6 pp

2.5%–3.5% FY

Below FY range (timing)

Adjusted EPS (Diluted)

$2.35

$1.21

$1.43

+18.2%

$8.20–$8.52 FY

~−1% vs. midpoint

Gross Profit – Operating ($M)

$1,253

$997

$1,082

+8.5%

~300 bps expansion Q2; >500 bps H2

Tracking guidance

NA Confectionery Sales ($M)

$2,490

$2,085

$2,049

−1.7%

N/A (segment)

N/A

NA Salty Snacks Sales ($M)

$350

$316

$379

+20.1%

N/A (segment)

N/A

Source: Visible Alpha Consensus and Actuals Data. Q2 2026 consensus as of July 29, 2026.

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

Quarter

KPI

Reported

Consensus

Surprise %

Result

Q1 2026

Adj. EPS

$2.35

$2.04

+15.2%

Beat

Q1 2026

Organic Sales

+7.9%

+6.0%

+1.9 pp

Beat

Q4 2025

Adj. EPS

$1.71

$1.39

+23.0%

Beat

Q4 2025

Organic Sales

+5.7%

+2.4%

+3.3 pp

Beat

Q3 2025

Adj. EPS

$1.30

$1.06

+22.6%

Beat

Q3 2025

Organic Sales

+6.2%

+4.0%

+2.2 pp

Beat

Q2 2025

Adj. EPS

$1.21

$1.03

+17.5%

Beat

Q2 2025

Organic Sales

+26.3%

+22.9%

+3.4 pp

Beat

Q1 2025

Adj. EPS

$2.09

$1.94

+7.7%

Beat

Q1 2025

Organic Sales

−13.2%

−13.4%

+0.2 pp

Slight Beat

Q4 2024

Adj. EPS

$2.69

$2.35

+14.5%

Beat

Q4 2024

Organic Sales

+9.0%

+7.2%

+1.8 pp

Beat

Q3 2024

Adj. EPS

$2.34

$2.58

−9.3%

Miss

Q3 2024

Organic Sales

−1.0%

+1.5%

−2.5 pp

Miss

Pattern: HSY has beaten on both adjusted EPS and organic sales in 7 of the last 8 quarters, with the lone miss in Q3 2024 driven by peak cocoa cost pressure. The consistent beat pattern reflects management’s tendency to guide conservatively; however, Q2 2026 is a deliberately guided-down quarter, so the beat threshold is lower than usual. Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Full-year 2026 guidance has been reaffirmed and unchanged since the Q1 print. Management’s tone at the May 12 Goldman Sachs conference was incrementally positive — elasticities running better than modeled, market share sequentially building — but no formal guidance revision has been issued. July 30 is the first opportunity to raise the full-year bar.

Metric

Initial Guidance (Q1 2026 Earnings, Apr 30)

Revised Guidance

Current Consensus

Note

Net Sales Growth

4%–5% (incl. ~150 bps LesserEvil benefit)

~4.3% (VA FY2026)

Unchanged; tracking low end of range

Organic Net Sales Growth

2.5%–3.5%

~2.9% (VA FY2026)

Unchanged; consensus near midpoint

Adjusted EPS (Diluted)

$8.20–$8.52

$8.43

Unchanged; consensus ~$0.07 above midpoint

Adjusted EPS Growth

30%–35%

~43% (off depressed 2025 base)

Unchanged; consensus above top of range

Gross Margin (Q2 2026)

~+300 bps YoY expansion

Tracking guidance

Unchanged; H2 expected >500 bps expansion

Marketing & Advertising

Double-digit increase FY2026

Tracking guidance

Unchanged; Q2 ramp confirmed at May conference

Capex

$425M–$475M

N/A

Unchanged

Q2 2026 Organic Sales

"Slightly negative" (timing-driven)

−1.3%

Consensus aligned with guidance; timing pull-forward from Q1 Easter

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates for Q2 2026 have drifted modestly lower since the Q1 print, consistent with management’s own timing guidance. Full-year estimates are essentially flat, suggesting the Street is waiting for a guidance raise before moving numbers. The gap between consensus and guidance midpoint is narrow, creating asymmetric upside if management raises at the midyear checkpoint.

KPI (Period)

Estimate ~5 Days Post Q1 Print (May 7, 2026)

Current Consensus (Jul 29, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Adj. EPS — Q2 2026

$1.43

$1.43

0.0%

No specific Q2 guidance

No specific Q2 guidance

N/A

Organic Sales — Q2 2026

−0.96%

−1.31%

∓0.35 pp

"Slightly negative"

"Slightly negative"

Unchanged

Aligned

Net Sales — Q2 2026 ($M)

$2,646

$2,636

−0.4%

No specific Q2 guidance

No specific Q2 guidance

N/A

Adj. EPS — FY 2026

$8.44

$8.43

−0.1%

$8.20–$8.52

$8.20–$8.52 (unchanged)

Unchanged

+$0.07 vs. midpoint (+0.8%)

Net Sales — FY 2026 ($M)

$12,252

$12,239

−0.1%

4%–5% growth

4%–5% growth (unchanged)

Unchanged

Tracking low end

Adj. EPS — FY 2027

$9.92

$9.87

−0.5%

No FY2027 guidance

No FY2027 guidance

N/A

Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline as of May 7, 2026 (5 trading days post-print).

Estimates have been remarkably stable since the Q1 print, with FY2026 EPS essentially flat and Q2 organic sales drifting only slightly more negative — consistent with management’s explicit timing guidance. The Street is holding its numbers, waiting for a midyear guidance raise. If management raises the FY2026 EPS range on July 30, consensus will likely move to $8.60–$8.80, representing ~2–4% upside to current numbers.

5. Stock Performance

Key Takeaway: HSY has underperformed both XLP and the S&P 500 since the Q1 earnings date, declining ~1.0% vs. XLP +3.6% and SPY +1.5%. The underperformance is driven almost entirely by multiple compression — NTM P/E has contracted from ~26.6x six months ago to ~19.8x today — as the market has de-rated the stock on execution risk and the pace of margin recovery. Estimate revisions have been flat, meaning the stock’s weakness is a valuation story, not an earnings story.

HSY vs. XLP vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings Date (April 30, 2026). Source: Yahoo Finance / Stock Price Data.

Period

HSY Return

XLP Return

SPY Return

HSY vs. XLP

NTM P/E (HSY)

Since Q1 Earnings (Apr 30)

−1.0%

+3.6%

+1.5%

−4.6 pp

~19.8x (current)

1 Month

+1.3%

N/A

N/A

N/A

~19.8x

3 Months

−2.1%

N/A

N/A

N/A

~13.5x (3M ago)

12 Months

−0.3%

N/A

N/A

N/A

~18.5x (12M ago)

Key Events Since Q1 Earnings: (1) Apr 30 — Q1 2026 earnings beat; stock declined on the day as results were anticipated. (2) Apr 14 — US President Andrew Archambault departure announced. (3) May 12 — Goldman Sachs Consumer Staples Forum; management reiterated confidence, elasticities better than modeled. (4) May 28 — Chief Supply Chain Officer Jason Reiman retirement announced; Mitchell Arends appointed effective June 22. (5) Jun 22 — Arends assumes CSO role. Source: Yahoo Finance / Stock Price Data; Visible Alpha (NTM P/E).

6. Material News & Developments

Key Takeaway: The most important development since Q1 earnings is the Mondelez Q2 2026 print (July 28) — MDLZ beat on organic sales (+2.2% vs. +0.9% expected) and raised full-year top-line guidance, providing a direct positive read-through for Hershey’s North America confectionery business and cocoa cost outlook. Leadership transitions (US President, CSO) are the key execution risk to monitor.

7. Peer Commentaries & Read-Through

Inclusion Screen: Only commentary from the last 60 days (May 29 – July 29, 2026) that is forward-looking about the current reporting period (Q2 2026 calendar quarter) or post-prior-earnings guidance/outlook is included. Backward-looking Q1 2026 results discussion from peers is excluded. Peers screened: MDLZ (Q2 2026 earnings July 28), GIS (Q4 FY2026 earnings July 1), CPB (Q3 FY2026 earnings June 8), KO (Q2 2026 earnings July 28), PG (Q4 FY2026 earnings July 29).

Key Takeaway: Peer commentary is net positive for HSY heading into Q2 — MDLZ’s North America beat and cocoa surplus commentary are the most direct read-throughs. GIS’s pivot to innovation and KO’s volume-driven beat confirm that branded consumer goods with strong equity can outperform in a pressured consumer environment. The common thread across all peers is that the consumer remains stressed but is still willing to pay for trusted brands.

Mondelez International (MDLZ) — Q2 2026 Earnings Call, July 28, 2026

Relevance: MDLZ is the most direct peer read-through for HSY — both are major North American chocolate/confectionery companies with significant cocoa exposure. MDLZ reported one day before HSY’s Q2 call.

General Mills (GIS) — Q4 FY2026 Earnings Call, July 1, 2026

Relevance: GIS is a broad packaged food peer with significant North America exposure. Q4 FY2026 covers the April–May 2026 period, overlapping with HSY’s Q2 2026.

Campbell’s Company (CPB) — Q3 FY2026 Earnings Call, June 8, 2026

Relevance: CPB is a packaged food peer with North America exposure. Q3 FY2026 covers the February–April 2026 period. Commentary about FY2027 outlook is forward-looking and relevant.

Coca-Cola (KO) — Q2 2026 Earnings, July 28, 2026

Relevance: KO is a large-cap consumer staples peer. Its Q2 2026 results (reported July 28) cover the same calendar period as HSY’s Q2 2026.

8. Insider Transaction Activity

Key Takeaway: All insider activity since the Q1 print is routine and plan-driven. The Hershey Trust continues its systematic 10b5-1 planned sales of ~10,000 shares per trading day — a long-standing structural program unrelated to company-specific views. CFO Steven Voskuil has made three small planned sales (~1,500 shares each) under a 10b5-1 plan established May 5, 2026. No discretionary open-market buys or unusual sale activity; nothing signals insider concern.

Name

Title

Transaction Type

Approx. Value

Date(s)

Note

Hershey Trust Co. (Milton Hershey School)

10% Owner

10b5-1 Planned Sale

~$1.7M–$1.8M per filing (10,000 shares/day)

Daily, Apr 30 – Jul 29, 2026

Systematic pre-planned program; structural, not discretionary. Trust has sold from ~1.74M to ~1.13M shares over the period.

Voskuil, Steven E.

SVP, Chief Financial Officer

10b5-1 Planned Sale

~$255,000 (1,500 shares)

Jul 20, 2026

10b5-1 plan established May 5, 2026; third sale under this plan.

Voskuil, Steven E.

SVP, Chief Financial Officer

10b5-1 Planned Sale

~$255,000 (1,500 shares)

Jun 18, 2026

10b5-1 plan; second sale.

Voskuil, Steven E.

SVP, Chief Financial Officer

10b5-1 Planned Sale

~$255,000 (1,500 shares)

May 18, 2026

10b5-1 plan; first sale.

Robbin-Coker, Cordel

Director

10b5-1 Planned Sale

~$22,000 (124 shares)

Jul 2, 2026

Small planned sale; routine.

Source: SEC Form 4 Filings Database. Open-market buys (Form 4 code P) and discretionary sales (code S) only, plus 10b5-1 planned sales. No open-market buys were filed in the period.

9. Key Risks & Questions for the Call

Key Risks

Key Questions for the Call

  1. Guidance Raise: "You said at the May Goldman Sachs conference that you’d have more visibility at the midyear mark to potentially take a different position on guidance. Given Q2 results and what you’re seeing in elasticities and H2 tentpole sell-in, are you raising full-year guidance today?"
  2. Cocoa Cost Outlook: "Mondelez yesterday cited a cocoa surplus of at least 500,000 metric tons and 10 months of industry coverage. Can you characterize your own cocoa coverage position for 2026 and 2027, and does the current market structure give you confidence in the 2027 margin recovery narrative?"
  3. Q2 Organic Sales Composition: "You guided Q2 organic sales to be slightly negative due to Easter timing pull-forward. Can you break down how much of the Q2 organic sales result was timing vs. underlying consumption trends? What did core branded consumption look like in April, May, and June?"
  4. CMG Market Share: "You flagged CMG market share pressure in Q1 from competitive innovation and merchandising. Did you see the sequential build-back in Q2 that you expected? What’s your current share position heading into Halloween?"
  5. H2 Gross Margin Confidence: "You guided >500 bps of gross margin expansion in H2. What gives you confidence in that number, and what are the key risks to achieving it? Has anything changed in your commodity or tariff cost assumptions since the Q1 call?"
  6. US President Search: "It’s been three months since Andrew Archambault’s departure. Can you update us on the US President search timeline and how the interim coverage structure is working?"
  7. Salty Snacks Segment: "You guided double-digit operating income growth for salty snacks in FY2026 after Q1 one-time items. Did Q2 salty margins recover as expected? How is the LesserEvil integration tracking?"
  8. Halloween Setup: "Can you give us early reads on Halloween sell-in and retailer support? How does the setup compare to last year, and what’s your confidence level in the H2 tentpole contribution of ~1 point of growth?"
  9. Premiumization: "The premium chocolate segment continues to outperform. You’ve characterized most premiumization initiatives as 2027 priorities. Is there any pull-forward of premium innovation into H2 2026, and how is the Hershey Krackel bar launch tracking?"
  10. Capital Allocation: "With the stock trading at ~20x NTM P/E and free cash flow recovering, how are you thinking about capital allocation priorities — buybacks, dividend growth, or M&A — as you move through the margin recovery?"